Back to search

University of Edinburgh

Restriction of SARS-CoV-2 infectivity by SERINC5 and SERINC3, and rescue by viral countermeasure proteins

Abstract

dc:description.abstract

Serine Incorporator (SERINC) proteins are cellular transmembrane proteins that have various functions, such as membrane lipid biosynthesis, tumour progression and nervous system function. SERINC5 and, to a lesser extent, SERINC3 have been shown to act as viral restriction factors. Host SERINCs are taken up into virus particles during assembly and restrict subsequent infection of target cells by inhibiting viral fusion. The HIV-1 antagonist Nef inhibits SERINC5 by binding directly to SERINC5 and excluding it from HIV-1 particles via endocytosis. Other SERINC5 antagonists include GlycoGag from Murine Leukaemia Virus, S2 from Equine Infectious Anaemia Virus and, recently discovered, ORF7a from SARS-CoV-2. This study aims to confirm the status of ORF7a as a SERINC antagonist using a lentiviral pseudotype model. It was investigated whether SARS-CoV-2 lentiviral pseudotypes co-transfected with SERINC5 and SERINC3 had restricted infectivity, and whether infectivity could be rescued using ORF7a and glygoGag viral countermeasures. In addition to laboratory approaches, sequence alignments and positive selection analysis were conducted on coronavirus ORF7a to understand the evolutionary pressures on ORF7a. This study shows that SERINC5 does not restrict the infectivity of SARS-CoV-2 lentiviral pseudotypes, and we are therefore unable to conclude whether ORF7a can rescue SARS-CoV-2 infectivity. We suggest that cellular and lentiviral pseudotype variation has an impact on the reproducibility of experiments, and that optimising the production of lentiviral pseudotypes for both research and clinical applications is a key area for further investigation. Bioinformatic analysis of ORF7a provides insight into the possible roles of ORF7a in supporting SARS-CoV-2 infection by subverting host immunity, potentially playing a role in the spread of the COVID-19 pandemic.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Collier, Hannah
Advisors dc:contributor.advisor
  • Sloan, Richard
  • Picozzi, Kim

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Collier, Hannah. Restriction of SARS-CoV-2 infectivity by SERINC5 and SERINC3, and rescue by viral countermeasure proteins. 2026. https://hdl.handle.net/1842/45512